NEVVI Medicare utilization intelligence
or

← back

Provider profile

SUZUKI, IKUMI M.D.

Medical Oncology · NPI 1457679458 · BALTIMORE, MD

1
Groups
24
Codes · 2024
48,015
Disclosed services

SUZUKI, IKUMI is a Medical Oncology in BALTIMORE, MD, a member of 1 medical group, who billed 24 distinct codes to Medicare Part B in 2024.

Groups: UNIVERSITY OF MARYLAND COMMUNITY MEDICAL GROUP INC (GLEN BURNIE, MD)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

48,015
disclosed services
24
codes billed to Medicare Part B
Prior year · CY2023 110,527 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
J0897 Injection, denosumab, 1 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
96372 Injection of drug or substance under skin or into muscle
J3475 Injection, magnesium sulfate, per 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
36415 Insertion of needle into vein for collection of blood sample
96413 Administration of chemotherapy into vein, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
36591 Collection of blood sample from implanted device
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3490 Unclassified drugs
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96523 Irrigation of implanted venous access drug delivery device

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.